TSPAN5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.204000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.788400E-01
Normal-vs-Stage2
3.783800E-01
Normal-vs-Stage3
9.956000E-01
Normal-vs-Stage4
3.683000E-01
Stage1-vs-Stage2
1.604260E-02
Stage1-vs-Stage3
9.801800E-01
Stage1-vs-Stage4
3.162000E-01
Stage2-vs-Stage3
3.067000E-01
Stage2-vs-Stage4
5.210800E-01
Stage3-vs-Stage4
3.229400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.284600E-01
Normal-vs-AfricanAmerican
7.406800E-01
Normal-vs-Asian
5.866200E-01
Caucasian-vs-AfricanAmerican
6.663900E-02
Caucasian-vs-Asian
5.436400E-01
AfricanAmerican-vs-Asian
6.330800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.902400E-01
Normal-vs-Female
3.507200E-01
Male-vs-Female
5.159000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.241200E-01
Normal-vs-Age(41-60Yrs)
2.139400E-01
Normal-vs-Age(61-80Yrs)
5.571600E-01
Normal-vs-Age(81-100Yrs)
7.041400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.870000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.618000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.109800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.419600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.362030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.324000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.909000E-01
Normal-vs-Daily Drinker
5.631400E-01
Normal-vs-Weekly Drinker
5.765400E-01
Normal-vs-Occasional Drinker
2.179200E-01
Normal-vs-Social Drinker
3.717800E-01
Non Drinker-vs-Daily Drinker
8.750200E-01
Non Drinker-vs-Weekly Drinker
8.669600E-01
Non Drinker-vs-Occasional Drinker
6.253800E-02
Non Drinker-vs-Social Drinker
5.142000E-01
Daily Drinker-vs-Weekly Drinker
9.700400E-01
Daily Drinker-vs-Occasional Drinker
5.833800E-02
Daily Drinker-vs-Social Drinker
3.963400E-01
Weekly Drinker-vs-Occasional Drinker
8.316400E-02
Weekly Drinker-vs-Social Drinker
4.305400E-01
Occasional Drinker-vs-Social Drinker
2.861000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.035200E-01
Normal-vs-Grade 2
8.621000E-01
Normal-vs-Grade 3
8.781000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.215400E-03
Grade 1-vs-Grade 3
3.059300E-03
Grade 1-vs-Grade 4
7.035200E-01
Grade 2-vs-Grade 3
2.736400E-01
Grade 2-vs-Grade 4
8.621000E-01
Grade 3-vs-Grade 4
8.781000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.211600E-01
Normal-vs-NonDiabetic
4.080800E-01
Diabetic-vs-NonDiabetic
9.166800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.181000E-01
Normal-vs-NoPancreatitis
4.392400E-01
Pancreatitis-vs-NoPancreatitis
2.638800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.558200E-01
Normal-vs-N1
3.903400E-01
N0-vs-N1
7.247800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.237800E-01
Normal-vs-TP53-NonMutant
7.439600E-01
TP53-Mutant-vs-TP53-NonMutant
7.9019000000069E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
